Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 8 at 2:00 PM EDT

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on November 4, 2021. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

National Mammography Quality Surveillance Act (MQSA) Non-Federal Inspection State Contracts Program

Closed
75F40122R00005Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 923120
New
Grant
Replicating Effective Teen Pregnancy Prevention (TPP) ProgramsThe Office of the Assistant Secretary for Health, under the Department of Health and Human Services, is soliciting applications for Fiscal Year 2026 grants to replicate evidence-based teen pregnancy prevention (TPP) programs through Solicitation Number AH-TP1-26-001, with a submission deadline of July 23, 2026. The initiative aims to empower adolescents by delivering medically accurate, age-appropriate education and counseling that enhances body literacy, supports informed consent, and promotes optimal health outcomes. Applicants must implement programs validated through rigorous evaluation and approved by the Office of Population Affairs, adhering strictly to the criteria outlined in Appendix A and meeting performance metrics defined in Appendix B. All program materials, including handouts, scripts, and participant guides, must undergo medical accuracy review by OPA prior to implementation, and grantees are required to observe at least 5% of program sessions to ensure fidelity. Projects must align with OASH priorities, maintain qualified staffing, and incorporate sustainable community-based delivery models with an anticipated project start date of September 30, 2026, and a total performance period of up to 24 months, extendable by a competitive third year. Funding is capped at $2 million per award, with budgets structured across personnel, equipment, supplies, contractual services, other costs, and indirect expenses calculated as a percentage of modified total direct costs. Applicants must comply with 2 CFR Part 200, as amended by 2 CFR Part 300, and adhere to stringent financial and administrative requirements, including segregation of duties for cash handling, accounting, and payroll functions, as well as compliance with the False Claims Act, the Program Fraud and Civil Remedies Act, Title VI, Title IX, Section 504 of the Rehabilitation Act, and other civil rights statutes. All applicants must maintain an active SAM.gov registration with a Unique Entity Identifier and complete a Grants.gov account, ensuring SAM registration precedes Grants.gov submission. Applications must be submitted in three separate files—a project narrative, a consolidated appendix file, and a budget package—formatted in 12-point Times New Roman or Arial with one-inch margins on 8.5" x 11" paper, and in acceptable formats such as PDF or Word; compressed, encrypted, or Excel files are disallowed. The evaluation process features mandatory pass/fail gates for eligibility, responsiveness, formatting, and submission compliance, followed by a merit review weighted toward technical approach (30 points), project
Office Of The Assistant Secretary For Health

POSTED

2 days ago

DEADLINE

in 29 days
NAICS: 923120
New
Grant
NAVIGATE Reproductive Center of Excellence (Network for Assessment, Validation, Innovation, Guidance, Access, Treatment and Evaluation)The Office of the Assistant Secretary for Health’s Office on Women’s Health is soliciting applications through a cooperative agreement to establish a Center of Excellence under the NAVIGATE Reproductive Center of Excellence initiative, aimed at reducing diagnostic delays and improving care coordination for critical reproductive health conditions including polyendocrine metabolic ovarian syndrome, endometriosis, uterine fibroids, infertility, pelvic inflammatory disease, reproductive-age endocrine disorders, and recurrent miscarriage. This opportunity, identified by solicitation number WH-AST-26-003 and Assistance Listing 93.088, is open to organizations with demonstrated expertise in prevention, diagnosis, and treatment of these conditions, with the goal of translating evidence into practice, standardizing root-cause clinical pathways, expanding workforce training, and improving health outcomes for women. Applicants must align their proposals with Make America Healthy Again (MAHA) priorities, focusing on prevention, early diagnosis, evidence-based clinical practice, patient-centered care, and scalable interventions, and are expected to deliver a comprehensive work plan that includes launching an expanded pilot, initiating baseline data collection, publishing a toolkit, and submitting a finalized dissemination and sustainability plan. The total period of performance is up to two years, structured in annual budget periods, with an optional competitive third year contingent on successful progress and submission of a non-competing continuation application. Proposals must be submitted via Grants.gov by July 24, 2026, and must adhere to strict formatting requirements including 8.5” x 11” page size, 12-point font in Times New Roman or Arial, and acceptable file formats such as PDF or Word; submissions in Excel, compressed files, or password-protected documents will be disqualified. Applications must include a complete Project Narrative, Appendices with resumes, organizational charts, and letters of commitment, and a fully justified Budget Package. Evaluations will be scored on a 100-point scale across six weighted factors: Need and Population Impact (30 points), Project Design and Approach (25 points), Organizational Capacity and Expertise (15 points), Evaluation and Performance Measurement (15 points), Training and Dissemination (10 points), and Budget Justification (5 points). Applicants must pass three mandatory gates—Responsiveness Review, Programmatic Technical Review, and Risk Assessment—which evaluate legal compliance, technical feasibility, financial stability, past performance, and management capability. Awards are subject to a $500,000 ceiling per award, require active SAM.gov
Office Of The Assistant Secretary For Health

POSTED

2 days ago

DEADLINE

in 30 days
NAICS: 923120
New
Federal
00HCCHD-2026-97923 Black Lung ServicesThe Centers for Disease Control and Prevention is moving forward with a sole source firm fixed price contract award to West Virginia University, Inc. to support coal miners by researching their perspectives on black lung screening and the use of low-dose computed tomography for lung health monitoring. The goal is to identify barriers and facilitators to participation in the Coal Workers’ Health Surveillance Program to improve outreach strategies and increase screening uptake, ultimately enhancing health outcomes for coal workers. The contract has a base performance period of one year beginning July 15, 2026, with two one-year options that could extend the work through July 14, 2029. This procurement is being conducted under federal acquisition regulations that permit non-competitive award due to the unique expertise and existing relationship of West Virginia University, Inc. with the program’s objectives, invoking authority under FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). While the notice is not a formal request for proposals, responses from other interested parties received by 7:00 AM ET on July 9, 2026, will be reviewed to determine whether competition is warranted, though the government retains full discretion to proceed without competition. All submissions must be sent to the designated Contract Specialist at dwb7@cdc.gov, and the contract is tied to NAICS code 923120 with performance based in Welch, West Virginia, under the oversight of the CDC Office of Acquisition Services in Atlanta, Georgia.
CDC Office Of Acquisition Services

POSTED

2 days ago

DEADLINE

in 14 days

General Info

Agency

Department Of Health And Human Services → FDA Office Of Regulatory AffairsView Agency

NAICS

923120 - Administration of Public Health Programs View NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Regulatory Affairs
Contacts1 person available
OfficeSilver Spring, MD, 20993, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Regulatory Affairs
View Agency Profile
Office AddressSilver Spring, MD, 20993, USA

Full Description

Show more
The Food and Drug Administration intends to award sole source contracts to State and/or local assistance in the inspection of certified non-Federal mammography facilities in order to document and report compliance with mammography quality standards issued under 21 CFR Part 900. The program meets the criteria set forth in 41 U.S.C. 253(c) (5). In accordance with the Mammography Quality Standards Act, the inspection services are restricted to state organizations possessing the authority necessary to conduct regulatory MQSA inspections. Contractors must meet the following special requirements: (1) possess legal authority under state law necessary to gain access to any regulated private commercial establishment for the unique purpose of conducting regulatory inspections and investigations to determine compliance with the Mammography Quality Standards Act at any geographical location within the state; (2) have trained personnel experienced with the inspectional procedures and evidence development techniques necessary to assess the conformance of an establishment with the federal law or comparable state requirements; (3) demonstrate experience with state regulatory procedures for correcting violative practices. Only governmental organizations have the unique qualification to perform this kind of activity. Competition within states does not exist for this program. Within any state, its legislature designates the governmental organizations which have the authority and resources to accomplish a program. The prospective contractors for this solicitation are those designated state organizations. This notice is issued for informational purposes and not a request for competitive proposals. Any interested party should submit a statement of capabilities in sufficient detail to determine if the requirements of this pre-solicitation can be met, no later than 15 days from the date of this announcement. A determination by the Government not to compete the proposed contracts based on responses from this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. The solicitation will be available on or the Second Quarter of Fiscal Year 2022on the SAM.gov website at http://www.sam.gov. Prospective offerors are responsible for downloading the solicitation and amendments. It is the offerors responsibility to monitor the SAM.gov website for the release of the solicitation and amendments. Hard copies will be provided to individuals eligible under the American with Disabilities Act and Rehabilitation Act upon request. Responses to this notice must be sent via email to: Michael.Gemmill@fda.hhs.gov. No phone calls will be accepted.